Literature DB >> 23945543

Oligoclonal expansions of mucosal T cells in Crohn's disease predominate in NKG2D-expressing CD4 T cells.

M Camus1, S Esses2, B Pariente3, L Le Bourhis1, C Douay4, V Chardiny1, I Mocan1, K Benlagha4, E Clave4, A Toubert4, L Mayer2, M Allez5.   

Abstract

Crohn's disease (CD) is an inflammatory pathology of the mucosal intestine that results from uncontrolled immune response towards commensal microbes. Clonal expansions of T cells have been found in patients with CD suggesting an antigen-specific stimulation of pathogenic T cells. Here we show, using T-cell receptor repertoire analysis by real-time PCR, that oligoclonal expansions are found in both CD8+ and CD4+ T cells in the blood and intestinal mucosa of CD patients. The majority of CD4+ T-cell-expanded clones are CD4+NKG2D+ T cells. These clonal expansions were found in both inflamed and neighboring healthy tissue and were persisting during the course of the disease. The presence of these CD4+NKG2D+ T-cell clones at the macroscopically normal edge of the surgical resection might be predictive of inflammation relapse post surgery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23945543     DOI: 10.1038/mi.2013.51

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  40 in total

Review 1.  Anatomical basis of tolerance and immunity to intestinal antigens.

Authors:  Allan McI Mowat
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

Review 2.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

Review 3.  Regulatory T cells: peace keepers in the gut.

Authors:  Matthieu Allez; Lloyd Mayer
Journal:  Inflamm Bowel Dis       Date:  2004-09       Impact factor: 5.325

4.  Reduced Paneth cell alpha-defensins in ileal Crohn's disease.

Authors:  Jan Wehkamp; Nita H Salzman; Edith Porter; Sabine Nuding; Michael Weichenthal; Robert E Petras; Bo Shen; Elke Schaeffeler; Matthias Schwab; Rose Linzmeier; Ryan W Feathers; Hiutung Chu; Heriberto Lima; Klaus Fellermann; Tomas Ganz; Eduard F Stange; Charles L Bevins
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

5.  Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study.

Authors:  Konstantinos Papamichael; Emmanuel Archavlis; Constantina Lariou; Gerassimos J Mantzaris
Journal:  J Crohns Colitis       Date:  2012-03-15       Impact factor: 9.071

6.  CD8+ cytotoxic T cells induce relapsing colitis in normal mice.

Authors:  Stéphane Nancey; Sébastien Holvöet; Ivan Graber; Grégoire Joubert; David Philippe; Stefan Martin; Jean-François Nicolas; Pierre Desreumaux; Bernard Flourié; Dominique Kaiserlian
Journal:  Gastroenterology       Date:  2006-08       Impact factor: 22.682

7.  Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells.

Authors:  V Groh; R Rhinehart; J Randolph-Habecker; M S Topp; S R Riddell; T Spies
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

8.  Selective expansion of specific T cell receptors in the inflamed colon of Crohn's disease.

Authors:  B Gulwani-Akolkar; P N Akolkar; A Minassian; R Pergolizzi; M McKinley; G Mullin; S Fisher; J Silver
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

Review 9.  The immunological and genetic basis of inflammatory bowel disease.

Authors:  Gerd Bouma; Warren Strober
Journal:  Nat Rev Immunol       Date:  2003-07       Impact factor: 53.106

10.  Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation.

Authors:  Emmanuel Clave; Marc Busson; Corinne Douay; Régis Peffault de Latour; Jeannig Berrou; Claire Rabian; Maryvonnick Carmagnat; Vanderson Rocha; Dominique Charron; Gérard Socié; Antoine Toubert
Journal:  Blood       Date:  2009-03-03       Impact factor: 22.113

View more
  13 in total

Review 1.  Immune Responses to Intestinal Microbes in Inflammatory Bowel Diseases.

Authors:  Jonathan J Hansen
Journal:  Curr Allergy Asthma Rep       Date:  2015-10       Impact factor: 4.806

2.  Quantitative Proteomics of Gut-Derived Th1 and Th1/Th17 Clones Reveal the Presence of CD28+ NKG2D- Th1 Cytotoxic CD4+ T cells.

Authors:  Tahira Riaz; Ludvig Magne Sollid; Ingrid Olsen; Gustavo Antonio de Souza
Journal:  Mol Cell Proteomics       Date:  2015-12-04       Impact factor: 5.911

3.  Enrichment of Circulating and Mucosal Cytotoxic CD8+ T Cells Is Associated with Postoperative Endoscopic Recurrence in Patients with Crohn's Disease.

Authors:  Gilles Boschetti; Stephane Nancey; Driffa Moussata; Eddy Cotte; Yves Francois; Bernard Flourié; Dominique Kaiserlian
Journal:  J Crohns Colitis       Date:  2015-11-19       Impact factor: 9.071

4.  Human Microbiota Flagellins Drive Adaptive Immune Responses in Crohn's Disease.

Authors:  Katie L Alexander; Qing Zhao; Meagan Reif; Alexander F Rosenberg; Peter J Mannon; Lennard Wayne Duck; Charles O Elson
Journal:  Gastroenterology       Date:  2021-05-07       Impact factor: 33.883

Review 5.  Understanding host-adherent-invasive Escherichia coli interaction in Crohn's disease: opening up new therapeutic strategies.

Authors:  Allison Agus; Sébastien Massier; Arlette Darfeuille-Michaud; Elisabeth Billard; Nicolas Barnich
Journal:  Biomed Res Int       Date:  2014-12-15       Impact factor: 3.411

6.  An approach to the immunophenotypic features of circulating CD4⁺NKG2D⁺ T cells in invasive cervical carcinoma.

Authors:  Mariel Garcia-Chagollan; Luis Felipe Jave-Suarez; Jesse Haramati; Miriam Ruth Bueno-Topete; Adriana Aguilar-Lemarroy; Ciro Estrada-Chavez; Blanca Estela Bastidas-Ramirez; Ana Laura Pereira-Suarez; Susana Del Toro-Arreola
Journal:  J Biomed Sci       Date:  2015-10-20       Impact factor: 8.410

7.  NK1.1- CD4+ NKG2D+ T cells suppress DSS-induced colitis in mice through production of TGF-β.

Authors:  Xingxing Qian; Chunxia Hu; Sen Han; Zhijie Lin; Weiming Xiao; Yanbing Ding; Yu Zhang; Li Qian; Xiaoqing Jia; Guoqiang Zhu; Weijuan Gong
Journal:  J Cell Mol Med       Date:  2017-02-22       Impact factor: 5.310

Review 8.  The Role of Natural Killer Group 2, Member D in Chronic Inflammation and Autoimmunity.

Authors:  Marina Babic; Chiara Romagnani
Journal:  Front Immunol       Date:  2018-05-30       Impact factor: 7.561

Review 9.  Anti-NKG2D mAb: A New Treatment for Crohn's Disease?

Authors:  Kasper Vadstrup; Flemming Bendtsen
Journal:  Int J Mol Sci       Date:  2017-09-16       Impact factor: 5.923

Review 10.  The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease.

Authors:  Ana Stojanovic; Margareta P Correia; Adelheid Cerwenka
Journal:  Front Immunol       Date:  2018-04-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.